NY A 9002
in committeeRelates to exemptions from the recipient restriction program
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 9002 pass?
Not yet. NY A 9002 is in committee as of 2026-03-31 and has not come to a final vote. Latest recorded action (2026-03-31): PRINT NUMBER 9002A
What is NY A 9002 about?
Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.
Who sponsors NY A 9002?
Jo Anne Simon is the primary sponsor of NY A 9002, joined by 2 cosponsors.
Description
Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.
- Introduced
- —
- Latest action
- 2026-03-31 — PRINT NUMBER 9002A
- Bill type
- bill
- Last updated
- —
Sponsors
- Jo Anne Simonprimary
- Phil Steckcosponsor
- Dana Levenbergcosponsor
Committees
Not provided by source.
Action timeline
2025-08-13
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
2026-03-31
AMEND AND RECOMMIT TO HEALTH
amendment-passage,referral-committee
2026-03-31
PRINT NUMBER 9002A
amendment-passage
Versions
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 7984
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 9002. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.